These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 31257510)
1. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510 [TBL] [Abstract][Full Text] [Related]
2. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy. Chen W; Li Y; Yuan D; Peng Y; Qin J Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Han L; Li YJ; Zhang WD; Song PP; Li H; Li S Medicine (Baltimore); 2019 Feb; 98(6):e13921. PubMed ID: 30732126 [TBL] [Abstract][Full Text] [Related]
4. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications. Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872 [TBL] [Abstract][Full Text] [Related]
5. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report. Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094 [TBL] [Abstract][Full Text] [Related]
6. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy. Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677 [No Abstract] [Full Text] [Related]
7. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900 [TBL] [Abstract][Full Text] [Related]
8. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy. Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559 [TBL] [Abstract][Full Text] [Related]
12. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma]. Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma. Sasaki K; Uchikado Y; Omoto I; Arigami T; Osako Y; Noda M; Okumura H; Maemura K; Higashi R; Yoshiura T; Natsugoe S Cancer Chemother Pharmacol; 2019 Mar; 83(3):581-587. PubMed ID: 30623230 [TBL] [Abstract][Full Text] [Related]
14. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial). Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448 [TBL] [Abstract][Full Text] [Related]
15. Intramural Metastasis as a Risk Factor for Recurrence in Esophageal Squamous Cell Carcinoma. Moon DH; Jeon JH; Yang HC; Kim YI; Lee JY; Kim MS; Lee JM; Lee GK Ann Thorac Surg; 2018 Jul; 106(1):249-256. PubMed ID: 29534955 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma. Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circulating tumour cells randomized controlled trial. Zhao Y; Han L; Zhang W; Shan L; Wang Y; Song P; Peng C; Zhao X Int J Surg; 2020 Jan; 73():1-8. PubMed ID: 31756547 [TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma. Lee HJ; Kim GH; Park SJ; Kwon CH; Lee MW; Lee BE; Baek DH; I H Gut Liver; 2021 Jul; 15(4):553-561. PubMed ID: 33293482 [TBL] [Abstract][Full Text] [Related]
20. Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy. Thalgott M; Rack B; Horn T; Heck MM; Eiber M; Kübler H; Retz M; Gschwend JE; Andergassen U; Nawroth R Anticancer Res; 2015 Oct; 35(10):5679-85. PubMed ID: 26408743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]